Cas12a-guided platform for precise multi-kilobase DNA insertion in dicot crops

Technology
In development
Company

Nulla Bio's Cas12a-targeted insertion platform enables precise 7–10 kb DNA integration in tomato, soybean, and oilseed rape. It combines geminiviral replicon donor amplification, NHEJ-suppression via KUDN tethering, SunTag-assembled donor recruitment, and a chemical-inducible timing layer to overcome bottlenecks in large-fragment insertion in dicot crops.

Overview

Nulla Bio offers a Cas12a-guided targeted-insertion platform designed to overcome the three linked bottlenecks that limit large-fragment DNA integration in dicot crops: insufficient donor availability, low productive donor use at the break site, and competing non-homologous end joining (NHEJ). The platform delivers precise, homology-directed repair (HDR)-resolved insertion of 7–10 kb payloads at predefined genomic loci, with a roadmap toward larger cargos and multi-locus stacking. It uses LbCas12a exclusively and operates within standard 25–30 °C regeneration windows, avoiding heat-shock steps. Phase 1 is anchored in tomato, with soybean and oilseed rape following in subsequent phases.

Technical specifications

Core technology layers:

  • Geminiviral replicon donor amplification raises donor copy number at the target site, leveraging bean yellow dwarf virus (BeYDV)-based replicon delivery previously shown to increase somatic gene targeting roughly three-fold with LbCas12a outperforming SpCas9.
  • KUDN-tethered Cas12a (a dominant-negative KU80 fusion) biases repair away from canonical NHEJ, previously demonstrated to improve gene targeting 1.7–3.55-fold across loci and up to 9.8-fold at a specific locus.
  • SunTag-assembled ORF1 donor recruitment concentrates donor DNA at the double-strand break, raising local donor availability at the editing site.
  • Chemical-inducible GR/Dex layer synchronizes donor build-up, donor release, and target cleavage within a single productive window, with a beta-estradiol/XVE variant available as backup induction.

Benchmarking and optimization variables:

  • Three configurations evaluated under matched conditions: SunTag-assembled ORF1 recruitment, a KUDN-Cas12a-ORF1-GR mega-fusion, and an external Cas12a-based comparator retained for benchmarking.
  • Tunable parameters include donor architecture, SunTag repeat number (5x/10x/24x), anchor-to-payload stoichiometry, dexamethasone dose, and induction timing and washout at 28–30 °C.
  • Event quality assessed by junction sequencing, copy-number analysis, backbone exclusion, and long-read confirmation.

Intellectual property: Three patent families (KR/US/CN/CA) protect the core platform components.

Technology readiness level

The platform builds on individually validated backbone layers from prior peer-reviewed work in tomato. Phase 1 (Year 1) benchmarks the three configurations in tomato against a defined go/no-go criterion of 2.5% precise single-copy insertion of a 7–10 kb payload. Achievement of this milestone triggers Phase 2 (Year 2), extending the platform to soybean with adapted induction dosing for cotyledonary-node explants and to oilseed rape via the R2S-T regeneration route validated in Brassica oleracea. A conditional Phase 3 addresses scaling toward 25 kb payloads and multi-locus stacking in allotetraploid Brassica napus. The technology is currently at a validated-component stage, with integrated platform performance being actively demonstrated.


About Nulla Bio Inc

Nulla Bio Inc. is a genome editing company specializing in crop innovation to address challenges in agriculture and food security. Founded in 2022 by Professor Jae-Yean Kim, the company utilizes advanced technologies such as prime editing to develop genetically enhanced crops, including functional tomatoes and cannabis with improved traits. Their core capabilities include proprietary gene-tagging, site-specific mutagenesis, and highly efficient transformation systems. The company operates as a research-intensive entity that provides specialized B2B services, including gene editing and research material development, to global researchers and agricultural enterprises.

By leveraging deep expertise in plant biology—specifically in areas like plasmodesmata and genetic regulation—Nulla Bio aims to create sustainable agricultural solutions, such as crops with increased nutritional value or removed harmful substances. Their technological advancements have been documented in leading scientific journals and secured through multiple international patents. Through these services and R&D activities, the company supports the wider plant research community, helping partners and clients save time and resources in developing climate-resilient and functional crop varieties.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.